Faruqi & Faruqi Investigates Kyndryl Securities Litigation
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy KD?
Source: Globenewswire
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential claims against Kyndryl Holdings, Inc., specifically urging investors who purchased securities between August 1, 2024, and February 9, 2026, to contact them before the April 13, 2026, deadline to seek lead plaintiff status.
- Financial Reporting Issues: On February 9, 2026, Kyndryl disclosed that its financial statements were materially misstated and that it lacked adequate internal controls, which resulted in the inability to timely file its Quarterly Report for the quarter ended December 31, 2025, potentially causing significant losses for investors.
- Executive Departures Impact: Kyndryl announced the immediate departures of its Chief Financial Officer and General Counsel, exacerbating market concerns regarding corporate governance and financial transparency, leading to a stock price decline of approximately 50% following the disclosures.
- Investor Rights Protection: Faruq & Faruqi LLP encourages anyone with information regarding Kyndryl's conduct, including whistleblowers and former employees, to come forward to provide legal support and information sharing for affected investors.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KD
Wall Street analysts forecast KD stock price to rise
4 Analyst Rating
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 12.950
Low
28.00
Averages
33.25
High
40.00
Current: 12.950
Low
28.00
Averages
33.25
High
40.00
About KD
Kyndryl Holdings, Inc. is a provider of mission-critical enterprise technology services offering advisory, implementation and managed service capabilities to customers in more than 60 countries. The Company designs, builds, manages and modernizes complex information systems around the world. Its segments include United States, Japan, Principal Markets and Strategic Markets. It offers services across domains, such as cloud services, core enterprise and zCloud services, applications, data and artificial intelligence (AI) services, digital workplace services, security and resiliency services and network and edge services. Its advisory and implementation services are branded as Kyndryl Consult. It provides end-to-end enterprise data services, including data transformation, data architecture and management, data governance and compliance and data migration. It provides comprehensive enterprise cybersecurity services for chief information security officers (CISOs) and chief risk officers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Multiple Companies Facing Class Action Lawsuits
- Oracle Lawsuit: Oracle Corporation faces a class action lawsuit for the period from June 12 to December 16, 2025, due to its AI infrastructure strategy leading to significant CapEx increases, which poses serious risks to its debt and credit rating, potentially affecting its ability to fund projects.
- Paysafe Issues: Paysafe Limited is being sued for the period from March 4 to November 12, 2025, for failing to disclose significant exposure to a single high-risk client, resulting in understated credit loss reserves that could negatively impact revenue growth.
- Inovio Pharmaceuticals Litigation: Inovio Pharmaceuticals, during the period from October 10, 2023, to December 26, 2025, faces a lawsuit alleging deficiencies in manufacturing its CELLECTRA device, which may hinder its ability to submit the INO-3107 BLA to the FDA on time, affecting regulatory and commercial prospects.
- Kyndryl Financial Misstatements: Kyndryl Holdings is under litigation for the period from August 1, 2024, to February 9, 2026, due to materially misstated financial statements and inadequate internal controls, which may prevent timely filing of its quarterly report, impacting investor confidence and company reputation.
See More
Kyndryl and Others Face Class Action Lawsuits
- Kyndryl Lawsuit Overview: Kyndryl Holdings, Inc. faces allegations of materially false statements regarding its financial reports from August 1, 2024, to February 9, 2026, which could mislead investors about the company's prospects, potentially impacting stock prices and investor confidence.
- PayPal Legal Issues: PayPal Holdings, Inc. is accused of failing to effectively execute its business initiatives between February 25, 2025, and February 2, 2026, which may undermine investor confidence in its competitive position, leading to stock price volatility.
- NuScale Risk Disclosure: NuScale Power Corporation is alleged to have failed to disclose significant risks to its commercialization strategy from May 13, 2025, to November 6, 2025, which could weaken investor confidence in its future growth prospects.
- Corcept Regulatory Challenges: Corcept Therapeutics Incorporated faces allegations of not disclosing FDA concerns regarding the effectiveness assessment of its drug from October 31, 2024, to January 30, 2026, potentially affecting its stock price and market performance.
See More
Faruqi & Faruqi Investigates Kyndryl Securities Litigation
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential claims against Kyndryl Holdings, Inc., specifically urging investors who purchased securities between August 1, 2024, and February 9, 2026, to contact them before the April 13, 2026, deadline to seek lead plaintiff status.
- Financial Reporting Issues: On February 9, 2026, Kyndryl disclosed that its financial statements were materially misstated and that it lacked adequate internal controls, which resulted in the inability to timely file its Quarterly Report for the quarter ended December 31, 2025, potentially causing significant losses for investors.
- Executive Departures Impact: Kyndryl announced the immediate departures of its Chief Financial Officer and General Counsel, exacerbating market concerns regarding corporate governance and financial transparency, leading to a stock price decline of approximately 50% following the disclosures.
- Investor Rights Protection: Faruq & Faruqi LLP encourages anyone with information regarding Kyndryl's conduct, including whistleblowers and former employees, to come forward to provide legal support and information sharing for affected investors.
See More
KYNDRYL HOLDINGS INC: MORGAN STANLEY REDUCES TARGET PRICE FROM $28 TO $13
Company Overview: Kyndryl Holdings is a company that has recently made headlines due to significant changes in its stock price.
Stock Price Adjustment: Morgan Stanley has cut the target price for Kyndryl's stock from $28 to $13, indicating a substantial decrease in expected value.
See More
Reminder of Kyndryl Securities Class Action
- Class Action Notice: Rosen Law Firm reminds investors who purchased Kyndryl securities between August 7, 2024, and February 9, 2026, to apply as lead plaintiffs by April 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Kyndryl made materially false statements during the class period regarding its financial statements and internal controls, resulting in the inability to timely file its Quarterly Report for the quarter ended December 31, 2025, causing investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked first in 2017 for the number of securities class action settlements, showcasing its expertise in this field.
- Investor Selection Advice: Investors are advised to carefully choose qualified counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure effective legal representation and support in litigation.
See More
Kyndryl Faces Class Action Lawsuit Risks
- Class Action Reminder: The Schall Law Firm alerts investors of a class action lawsuit against Kyndryl Holdings, Inc. for violations of securities laws, involving securities transactions from August 7, 2024, to February 9, 2026, with a deadline for participation by April 13, 2026.
- Financial Misstatements: The complaint alleges that Kyndryl materially misstated its financial statements and failed to maintain adequate internal controls, rendering its public statements false and misleading, which resulted in investor losses when the truth emerged.
- Legal Proceedings Status: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who take no action will remain absent class members, potentially forfeiting their ability to recover losses.
- Investor Rights Protection: The Schall Law Firm specializes in securities class action lawsuits and encourages affected investors to reach out to discuss their rights, highlighting the firm's commitment to protecting the rights of investors globally.
See More
Multiple Companies Facing Class Action Lawsuits
- Oracle Lawsuit: Oracle Corporation faces a class action lawsuit for the period from June 12 to December 16, 2025, due to its AI infrastructure strategy leading to significant CapEx increases, which poses serious risks to its debt and credit rating, potentially affecting its ability to fund projects.
- Paysafe Issues: Paysafe Limited is being sued for the period from March 4 to November 12, 2025, for failing to disclose significant exposure to a single high-risk client, resulting in understated credit loss reserves that could negatively impact revenue growth.
- Inovio Pharmaceuticals Litigation: Inovio Pharmaceuticals, during the period from October 10, 2023, to December 26, 2025, faces a lawsuit alleging deficiencies in manufacturing its CELLECTRA device, which may hinder its ability to submit the INO-3107 BLA to the FDA on time, affecting regulatory and commercial prospects.
- Kyndryl Financial Misstatements: Kyndryl Holdings is under litigation for the period from August 1, 2024, to February 9, 2026, due to materially misstated financial statements and inadequate internal controls, which may prevent timely filing of its quarterly report, impacting investor confidence and company reputation.
See More
Kyndryl and Others Face Class Action Lawsuits
- Kyndryl Lawsuit Overview: Kyndryl Holdings, Inc. faces allegations of materially false statements regarding its financial reports from August 1, 2024, to February 9, 2026, which could mislead investors about the company's prospects, potentially impacting stock prices and investor confidence.
- PayPal Legal Issues: PayPal Holdings, Inc. is accused of failing to effectively execute its business initiatives between February 25, 2025, and February 2, 2026, which may undermine investor confidence in its competitive position, leading to stock price volatility.
- NuScale Risk Disclosure: NuScale Power Corporation is alleged to have failed to disclose significant risks to its commercialization strategy from May 13, 2025, to November 6, 2025, which could weaken investor confidence in its future growth prospects.
- Corcept Regulatory Challenges: Corcept Therapeutics Incorporated faces allegations of not disclosing FDA concerns regarding the effectiveness assessment of its drug from October 31, 2024, to January 30, 2026, potentially affecting its stock price and market performance.
See More
Faruqi & Faruqi Investigates Kyndryl Securities Litigation
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential claims against Kyndryl Holdings, Inc., specifically urging investors who purchased securities between August 1, 2024, and February 9, 2026, to contact them before the April 13, 2026, deadline to seek lead plaintiff status.
- Financial Reporting Issues: On February 9, 2026, Kyndryl disclosed that its financial statements were materially misstated and that it lacked adequate internal controls, which resulted in the inability to timely file its Quarterly Report for the quarter ended December 31, 2025, potentially causing significant losses for investors.
- Executive Departures Impact: Kyndryl announced the immediate departures of its Chief Financial Officer and General Counsel, exacerbating market concerns regarding corporate governance and financial transparency, leading to a stock price decline of approximately 50% following the disclosures.
- Investor Rights Protection: Faruq & Faruqi LLP encourages anyone with information regarding Kyndryl's conduct, including whistleblowers and former employees, to come forward to provide legal support and information sharing for affected investors.
See More
KYNDRYL HOLDINGS INC: MORGAN STANLEY REDUCES TARGET PRICE FROM $28 TO $13
Company Overview: Kyndryl Holdings is a company that has recently made headlines due to significant changes in its stock price.
Stock Price Adjustment: Morgan Stanley has cut the target price for Kyndryl's stock from $28 to $13, indicating a substantial decrease in expected value.
See More
Reminder of Kyndryl Securities Class Action
- Class Action Notice: Rosen Law Firm reminds investors who purchased Kyndryl securities between August 7, 2024, and February 9, 2026, to apply as lead plaintiffs by April 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Kyndryl made materially false statements during the class period regarding its financial statements and internal controls, resulting in the inability to timely file its Quarterly Report for the quarter ended December 31, 2025, causing investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked first in 2017 for the number of securities class action settlements, showcasing its expertise in this field.
- Investor Selection Advice: Investors are advised to carefully choose qualified counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure effective legal representation and support in litigation.
See More
Kyndryl Faces Class Action Lawsuit Risks
- Class Action Reminder: The Schall Law Firm alerts investors of a class action lawsuit against Kyndryl Holdings, Inc. for violations of securities laws, involving securities transactions from August 7, 2024, to February 9, 2026, with a deadline for participation by April 13, 2026.
- Financial Misstatements: The complaint alleges that Kyndryl materially misstated its financial statements and failed to maintain adequate internal controls, rendering its public statements false and misleading, which resulted in investor losses when the truth emerged.
- Legal Proceedings Status: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who take no action will remain absent class members, potentially forfeiting their ability to recover losses.
- Investor Rights Protection: The Schall Law Firm specializes in securities class action lawsuits and encourages affected investors to reach out to discuss their rights, highlighting the firm's commitment to protecting the rights of investors globally.
See More
